一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Advanced Science >>article
Advanced Science

Advanced Science

IF: 14.3
Download PDF

Design and Characterization of a Novel eEF2K Degrader with Potent Therapeutic Efficacy Against Triple-Negative Breast Cancer

Published:12 December 2023 DOI:
Changxin Zhong, Rongfeng Zhu, Ting Jiang, Sheng Tian, Xiaobao Zhao, Xiaoya Wan, Shilong Jiang, Zonglin Chen, Rong Gong, Linhao He, Jin-Ming Yang, Na Ye, Yan Cheng

Abstract

Dysregulated eEF2K expression is implicated in the pathogenesis of many human cancers, including triple-negative breast cancer (TNBC), making it a plausible therapeutic target. However, specific eEF2K inhibitors with potent anti-cancer activity have not been available so far. Targeted protein degradation has emerged as a new strategy for drug discovery. In this study, a novel small molecule chemical is designed and synthesized, named as compound C1, which shows potent activity in degrading eEF2K. C1 selectively binds to F8, L10, R144, C146, E229, and Y236 of the eEF2K protein and promotes its proteasomal degradation by increasing the interaction between eEF2K and the ubiquitin E3 ligase βTRCP in the form of molecular glue. C1 significantly inhibits the proliferation and metastasis of TNBC cells both in vitro and in vivo and in TNBC patient-derived organoids, and these antitumor effects are attributed to the degradation of eEF2K by C1. Additionally, combination treatment of C1 with paclitaxel, a commonly used chemotherapeutic drug, exhibits synergistic anti-tumor effects against TNBC. This study not only generates a powerful research tool to investigate the therapeutic potential of targeting eEF2K, but also provides a promising lead compound for developing novel drugs for the treatment of TNBC and other cancers.

Substances (5)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
Pevonedistat 905579-51-3 C21H25N5O4S 201 suppliers $27.00-$4735.50
Pevonedistat 905579-51-3 C21H25N5O4S 201 suppliers $27.00-$4735.50
Pevonedistat 905579-51-3 C21H25N5O4S 201 suppliers $27.00-$4735.50
Pevonedistat 905579-51-3 C21H25N5O4S 201 suppliers $27.00-$4735.50

Similar articles

IF:10.5

Self-assembling mertansine prodrug improves tolerability and efficacy of chemotherapy against metastatic triple-negative breast cancer

Journal of Controlled Release Wei Ran , Xiaoyu Liu ,etc Published: 1 February 2020
IF:10

Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer

Advanced Healthcare Materials Jiali Gong, Danling Cheng,etc Published: 21 November 2024
IF:4.6

Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer.

iScience Xu Yang,?Li Deng,etc Published: 16 October 2023
永定县| 江油市| 咸丰县| 洪江市| 内江市| 岳池县| 隆化县| 乐至县| 阳曲县| 垦利县| 长沙市| 南昌市| 石景山区| 贺兰县| 清流县| 成武县| 湘潭县| 庆云县| 时尚| 吴忠市| 广汉市| 响水县| 平山县| 岑溪市| 勃利县| 左贡县| 台山市| 玉田县| 鄂尔多斯市| 望都县| 枣阳市| 兴海县| 正蓝旗| 海城市| 扶余县| 虞城县| 耿马| 连云港市| 昆明市| 泾源县| 阆中市|